Breast cancer is one of the most common cancers affecting women globally. It starts when cells in the breast grow abnormally, often forming a lump or mass. Detecting breast cancer early is crucial for ...

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

A new investigational drug called gedatolisib can help keep cancer from returning for longer for certain patients with HR+, ...

Orserdu (elacestrant) is a targeted hormonal therapy for breast cancer. Unlike chemotherapy, which can harm both healthy and cancer cells, targeted therapy aims at specific proteins in the cancer ...

For millions of American women, hormone replacement therapy (HRT) has provided relief from side effects of menopause. As the ovaries stop releasing eggs, a woman’s body also stops producing the ...

There is mounting evidence to suggest GLP-1 drugs designed as diabetes and obesity treatments also help reduce cancer risk.

Development and Validation of a Natural Language Processing Algorithm for Extracting Clinical and Pathological Features of Breast Cancer From Pathology Reports Overall, 32 symptoms and nine impacts ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Intrauterine devices (IUDs) can increase breast cancer risk by a similar margin compared to contraceptive pills, a recent study found. Image credit: Martí Sans/Stocksy. IUDs are the third most common ...

Drs Ursula A. Matulonis and Panagiotis A. Konstantinopoulos discuss hormonal therapy updates and different ways to target and treat ER+ metastatic endometrial cancer. Drs Ursula A. Matulonis and ...